Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income	$ (12,508)	$ (58,750)
Depreciation and amortization	171,615	178,338
Amortization of Inventory Step-up	0	22,676
Noncash lease expense	16,543	17,382
Provision for doubtful accounts	865	214
Provision for warranty and returns	5,597	3,439
Stock compensation	29,878	28,597
Loss on disposal of property and equipment	1,757	2,391
Bond premium amortization	14	254
Debt Issuance Costs amortization	5,108	5,254
Change in fair value of contingent earn-out	(12,256)	(31,253)
Sparepartsusage	13,587	7,915
Other Noncash Income (Expense)	4,393	(2,855)
Accounts receivable	43,086	(8,956)
Inventories	(66,662)	(151,840)
Prepaid expenses and other assets	11,295	20,074
Increase (Decrease) in Other Operating Assets	(18,860)	(22,594)
Accounts payable	(65,049)	30,413
Accrued liabilities	(10,532)	(38,070)
Income taxes, including excess tax benefits and deferred income taxes	(42,939)	(63,047)
Net cash provided by operating activities	74,932	(60,418)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(53,956)	(68,715)
Proceeds from sale of asset	1,481	933
Intangible assets additions	(7,742)	(6,560)
Purchases of investment securities	0	(3,397)
Proceeds from sale of investment securities	2,920	36,433
Net cash used in investing activities	(57,297)	(1,885,470)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	0	1,672,631
Repayments of Long-term Debt	22,250	20,250
Payments of Debt Issuance Costs	0	(1,852)
Proceeds from exercise of stock options	4,022	7,906
Finance Lease, Principal Payments	(681)	(477)
Payment, Tax Withholding, Share-based Payment Arrangement	9,221	10,541
Net cash (used in) provided by financing activities	(28,130)	1,647,417
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(1,097)	(10,477)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(11,592)	(308,948)
Cash and Cash Equivalents	197,192	243,879
Supplemental Cash Flow Information [Abstract]
Capital Expenditures Incurred but Not yet Paid	3,712	2,757
NON-CASH INVESTING ACTIVITIES
Payments to Acquire Businesses, Net of Cash Acquired	0	(1,844,164)
SmithsMedical
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income		79,000
Change in fair value of contingent earn-out	$ 12,300	31,300
NON-CASH INVESTING ACTIVITIES
Fair Value of Assets Acquired		1,658,937
Net Cash Paid (Received) for current and prior acquisitions		(1,844,164)
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		(575,975)
Business Combination, Liabilities Arising from Contingencies, Amount Recognized		(55,158)
Goodwill, Period Increase (Decrease)		1,442,849
Liabilities Assumed		$ (626,489)